Pulmonary hypertension historical perspective: Difference between revisions

Jump to navigation Jump to search
Line 7: Line 7:
*[[Dresdale]] investigated the effects of [[tolzoline]] in a woman with [[pulmonary arterial hypertension]] causing a sudden reduction in pulmonary vascular resistance;
*[[Dresdale]] investigated the effects of [[tolzoline]] in a woman with [[pulmonary arterial hypertension]] causing a sudden reduction in pulmonary vascular resistance;
*In the late 1960s there was an epidemic of [[pulmonary arterial hypertension]] induced by aminorex which sparked interest on the disease.
*In the late 1960s there was an epidemic of [[pulmonary arterial hypertension]] induced by aminorex which sparked interest on the disease.
*[[Pulmonary hypertension]] was first classified into primary and secondary in 1973 during the World Health Organization (WHO) meeting on PH in Geneva, Switzerland.
*[[Pulmonary hypertension]] was first classified into primary and secondary in 1973 during the World Health Organization (WHO) meeting on PH in Geneva, Switzerland.<ref name="pmid19561874">{{cite journal| author=Barst RJ| title=Pulmonary hypertension: past, present and future. | journal=Ann Thorac Med | year= 2008 | volume= 3 | issue= 1 | pages= 1-4 | pmid=19561874 | doi=10.4103/1817-1737.37832 | pmc=2700428 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19561874  }} </ref>
<ref name="pmid19561874">{{cite journal| author=Barst RJ| title=Pulmonary hypertension: past, present and future. | journal=Ann Thorac Med | year= 2008 | volume= 3 | issue= 1 | pages= 1-4 | pmid=19561874 | doi=10.4103/1817-1737.37832 | pmc=2700428 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19561874  }} </ref>


==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 15:43, 25 April 2021

Pulmonary Hypertension Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary hypertension from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pulmonary hypertension historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Pulmonary hypertension historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary hypertension historical perspective

CDC on Pulmonary hypertension historical perspective

Pulmonary hypertension historical perspective in the news

Blogs on Pulmonary hypertension historical perspective

Directions to Hospitals Treating Pulmonary hypertension

Risk calculators and risk factors for Pulmonary hypertension historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]: Associate Editor(s)-in-Chief: Anthony Gallo, B.S. [2]

Overview

Historical Perspective

References

  1. Barst RJ (2008). "Pulmonary hypertension: past, present and future". Ann Thorac Med. 3 (1): 1–4. doi:10.4103/1817-1737.37832. PMC 2700428. PMID 19561874.